- About Overview
- Honors and Awards
- Facts and Figures
- Support the School
- Contact Us
- Dean’s Office
- Dean’s Office Overview
- Education Unit
- Office of Faculty Academic Affairs
- Office of Administration
- Org Chart
- Patient Care
Vogt named president of American Pharmacists Association Foundation board
By Grant Burningham / Thu Apr 26, 2018
Eleanor Vogt, PhD, RPh, has been named the president of the board of directors for the American Pharmacists Association Foundation (APhAF).
Vogt has had a distinguished career working in clinical pharmacy practice, the pharmaceutical industry, health policy and planning, regulatory affairs, and patient safety and advocacy, and even as a TV pharmacist, answering questions for the public in the 1970s.
She was the first consumer representative on an FDA technical review committee, and served as Senior Fellow for the AMA’s National Patient Safety Foundation, testifying before Congress on this issue.
Vogt joined the faculty of the UCSF School of Pharmacy’s Department of Clinical Pharmacy in 2004 and was awarded the UCSF Presidential Chair for 2004-2005.
The APhAF is the research arm of the American Pharmacists Association (APhA), an organization representing 64,000 practicing pharmacists, dedicated to helping all pharmacists improve medication use and advance patient care.
“APhA is the advocacy voice for the profession, but APhAF is the research voice,” Vogt said. “We give 14 scholarships every year, and we’ve been doing landmark research in diabetes, immunization care, and patient credentialing, in which patients are taught to be an active part of their care.”
The foundation was selected by the Center for Disease Control to implement Project IMPACT: Diabetes Prevention, an innovative program that will deliver the National Diabetes Prevention Program to at least 7,500 at-risk adults in underserved communities in the United States over the next five years.
About the School: The UCSF School of Pharmacy aims to solve the most pressing health care problems and strives to ensure that each patient receives the safest, most effective treatments. Our discoveries seed the development of novel therapies, and our researchers consistently lead the nation in NIH funding. The School’s doctor of pharmacy (PharmD) degree program, with its unique emphasis on scientific thinking, prepares students to be critical thinkers and leaders in their field.